0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug/Vaccine Safety
 41-60 of 129 Articles
Research Letter |  FREE
Sandeep S. Mangalmurti, MD, JD; John Gordon Harold, MD; Parul Divya Parikh, MPH; et al.
JAMA Intern Med. 2014;174(6):993-995. doi:10.1001/jamainternmed.2014.1116.

Original Investigation |  FREE
Jane A. Gwira Baumblatt, MD; Caleb Wiedeman, MPH; John R. Dunn, DVM, PhD; et al.
JAMA Intern Med. 2014;174(5):796-801. doi:10.1001/jamainternmed.2013.12711.

Invited Commentary | 
Allan Coukell, BScPharm
JAMA Intern Med. 2014;174(4):613-614. doi:10.1001/jamainternmed.2013.12812.

Research Letter |  FREE
John M. Boyce, MD; Lorraine Lee, MHA, BSPharm; Jeffrey Topal, MD; et al.
JAMA Intern Med. 2014;174(4):630-631. doi:10.1001/jamainternmed.2013.13772.

Original Investigation |  FREE
Rebekah W. Moehring, MD, MPH; Sarah S. Lewis, MD; Pamela J. Isaacs, BSN, MHA; et al.
JAMA Intern Med. 2014;174(4):606-612. doi:10.1001/jamainternmed.2013.13768.
Includes: Supplemental Content

Special Communication | 
Steven Woloshin, MD, MS; Lisa M. Schwartz, MD, MS
JAMA Intern Med. 2014;174(4):615-619. doi:10.1001/jamainternmed.2013.14629.

Invited Commentary | 
Seamus P. Whelton, MD, MPH; Sandeep Bansal, MD, MPH
JAMA Intern Med. 2014;174(3):345-346. doi:10.1001/jamainternmed.2013.11341.

Case Report/Case Series |  FREE
Frank M. Sacks, MD; Maxine Stanesa, PA-C; Robert A. Hegele, MD
JAMA Intern Med. 2014;174(3):443-447. doi:10.1001/jamainternmed.2013.13309.

Original Investigation |  FREE
Nathan P. Clark, PharmD; Thomas Delate, PhD; Catherine S. Riggs, PharmD; et al.
JAMA Intern Med. 2014;174(3):409-416. doi:10.1001/jamainternmed.2013.13957.
Includes: Supplemental Content

Viewpoint | 
Nathaniel P. Morris, AB
JAMA Intern Med. 2014;174(2):177-178. doi:10.1001/jamainternmed.2013.12376.

Research Letter |  FREE
Ilke Sipahi, MD; Seden Celik, MD; Nurdan Tozun, MD
JAMA Intern Med. 2014;174(1):150-151. doi:10.1001/jamainternmed.2013.12217.

Original Investigation |  FREE
Nicholas L. Smith, PhD; Marc Blondon, MD, MS; Kerri L. Wiggins, MS, RD; et al.
JAMA Intern Med. 2014;174(1):25-34. doi:10.1001/jamainternmed.2013.11074.
Includes: Supplemental Content

Invited Commentary | 
Daniel Carpenter, PhD
JAMA Intern Med. 2014;174(1):95-97. doi:10.1001/jamainternmed.2013.9202.

Original Investigation |  FREE
Thomas J. Moore, AB; Curt D. Furberg, MD, PhD
JAMA Intern Med. 2014;174(1):90-95. doi:10.1001/jamainternmed.2013.11813.

Research Letter |  FREE
Peter Doshi, PhD
JAMA Intern Med. 2013;173(21):2009-2011. doi:10.1001/jamainternmed.2013.9989.
Includes: Supplemental Content

Comment & Response | 
Arief Lalmohamed, PharmD; Niels Vermeer, PharmD; Frank de Vries, PharmD, PhD
JAMA Intern Med. 2013;173(16):1559. doi:10.1001/jamainternmed.2013.8468.

Comment & Response | 
Marcello Maggio, MD, PhD; Andrea Corsonello, MD
JAMA Intern Med. 2013;173(16):1559-1560. doi:10.1001/jamainternmed.2013.8459.

Viewpoint | 
Robert J. Smith, MD; William R. Hiatt, MD
JAMA Intern Med. 2013;173(16):1491-1492. doi:10.1001/jamainternmed.2013.6624.

Comment and Response | 
David L. Keller, MD
JAMA Intern Med. 2013;173(15):1473. doi:10.1001/jamainternmed.2013.7747.

Comment and Response | 
Brian K. Alldredge, PharmD; Steven R. Kayser, PharmD
JAMA Intern Med. 2013;173(15):1473. doi:10.1001/jamainternmed.2013.7701.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Neurology
Viewpoint  | 
The Importance of Lesbian, Gay, Bisexual, and Transgender Health in Neurology:  What’s in a Name?
Nicole Rosendale, MD; S. Andrew Josephson, MD
JAMA Ophthalmology
Brief Report  | 
Association of Rivaroxaban Anticoagulation and Spontaneous Vitreous Hemorrhage
Judy H. Jun, BS; John C. Hwang, MD, MBA
JAMA Oncology
Brief Report  | 
Nephrotoxicity of the BRAF Inhibitors Vemurafenib and Dabrafenib
Kenar D. Jhaveri, MD; Vipulbhai Sakhiya, MBBS; Steven Fishbane, MD
JAMA Oncology
Invited Commentary  | 
JAK/STAT Pathway Inhibitors and Neurologic Toxicity:  Above All Else Do No Harm?
Bart L. Scott, MD; Pamela S. Becker, MD, PhD